Insider: Patel Sanjiv President and CEO - Relay Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 783,927 | 199,548 | 983,475 |
| Value | $3,508,073.33 | $892,977.30 | $4,401,050.63 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 07/09/2025 | DDS | 42,740 | Direct | COM | $3.57 | $152,581.80 | 783,927 |
| 07/09/2025 | DDS | 18,639 | Direct | COM | $3.57 | $66,541.23 | 765,288 |
| 04/23/2025 | DDS | 42,769 | Direct | COM | $2.97 | $127,023.93 | 840,320 |
| 04/23/2025 | DDS | 18,653 | Direct | COM | $2.97 | $55,399.41 | 821,667 |
| 02/13/2025 | DDS | 75,324 | Direct | COM | $3.70 | $278,698.80 | 883,089 |
| 02/11/2025 | DDS | 140,182 | Direct | COM | $3.85 | $539,700.70 | 625,948 |
| 01/23/2025 | DDS | 125,000 | Indirect | COM | $4.78 | $597,500.00 | 199,548 |
| 01/22/2025 | DDS | 125,000 | Indirect | COM | $4.80 | $600,000.00 | 324,548 |
| 01/21/2025 | DDS | 125,000 | Indirect | COM | $4.52 | $565,000.00 | 449,548 |
| 12/16/2024 | DDS | 100,000 | Indirect | COM | $5.00 | $500,000.00 | 574,548 |
| 02/09/2023 | DDS | 14,000 | Direct | COM | $20.55 | $287,700.00 | 0 |
| 02/08/2023 | DDS | 14,000 | Direct | COM | $20.98 | $293,720.00 | 0 |
| 02/07/2023 | DDS | 14,000 | Direct | COM | $21.45 | $300,300.00 | 0 |
| 01/19/2023 | DDS | 28,000 | Direct | COM | $20.02 | $560,560.00 | 254,554 |
| 01/18/2023 | DDS | 28,000 | Direct | COM | $20.87 | $584,360.00 | 254,554 |
| 01/17/2023 | DDS | 28,000 | Direct | COM | $20.23 | $566,440.00 | 254,554 |
| 11/10/2022 | DDS | 9,825 | Direct | COM | $20.00 | $196,500.00 | 254,554 |
| 11/10/2022 | DDS | 18,175 | Direct | COM | $20.00 | $363,500.00 | 254,554 |
| 11/08/2022 | DDS | 14,000 | Direct | COM | $20.18 | $282,520.00 | 254,554 |
| 10/13/2022 | DDS | 14,000 | Direct | COM | $20.58 | $288,120.00 | 254,554 |
| 10/12/2022 | DDS | 14,000 | Direct | COM | $21.18 | $296,520.00 | 254,554 |
| 10/11/2022 | DDS | 14,000 | Direct | COM | $21.36 | $299,040.00 | 254,554 |
| 09/15/2022 | DDS | 14,000 | Direct | COM | $23.80 | $333,200.00 | 254,554 |
| 09/14/2022 | DDS | 14,000 | Direct | COM | $23.47 | $328,580.00 | 254,554 |
| 09/13/2022 | DDS | 14,000 | Direct | COM | $25.45 | $356,300.00 | 254,554 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research